XWELL (NASDAQ:XWEL) Announces Quarterly Earnings Results

XWELL (NASDAQ:XWEL) posted its quarterly earnings data on Friday. The company reported ($0.26) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.60) by $0.34, Zacks reports. XWELL had a negative net margin of 81.43% and a negative return on equity of 2,318.99%.

XWELL Trading Down 3.0%

NASDAQ XWEL traded down $0.03 on Friday, reaching $0.98. 10,722 shares of the stock were exchanged, compared to its average volume of 3,547,599. The company’s 50-day simple moving average is $1.08 and its two-hundred day simple moving average is $1.08. XWELL has a one year low of $0.26 and a one year high of $2.20. The firm has a market capitalization of $8.27 million, a PE ratio of -0.17 and a beta of 1.03.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on XWEL. Wall Street Zen cut XWELL from a “hold” rating to a “sell” rating in a research note on Sunday, May 17th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of XWELL in a report on Friday, August 7th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock has an average rating of “Sell”.

XWELL Company Profile

XWELL, Inc provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels.